Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: 
implications for HIV/AIDS treatment

Li, Jing; Menard, Vincent; Benish, Rebekah L; Jurevic, Richard J; Guillemette, Chantal; Stoneking, Mark; Zimmerman, Peter A; Mehlotra, Rajeev K

doi:10.2217/pgs.11.160

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment

MPS-Authors

/persons/resource/persons72822

Li, Jing
Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Max Planck Society;

/persons/resource/persons72992

Stoneking, Mark
Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Max Planck Society;
Human Population History, Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Li, J., Menard, V., Benish, R. L., Jurevic, R. J., Guillemette, C., Stoneking, M., et al. (2012). Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment. Pharmacogenomics, 13(5), 555-570. doi:10.2217/pgs.11.160.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-17FA-F

Abstract

There is no abstract available